SCHEMBL10038693

SCHEMBL10038693

[C-]#[N+]c1ccc(N(c2ccc(C(C)(C)C)cc2)c2cc(CC)c3ccc4c(N(c5ccc(C#N)cc5)c5ccc(C(C)(C)C)cc5)cc(CC)c5ccc2c3c54)cc1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.37
MLYCD O95822 1/20 0.35
EPHX2 P34913 1/20 0.34
HDAC8 Q9BY41 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068519 0.91 KIF11 (0.44) KIF11MLYCDEPHX2
SCHEMBL10038690 0.88 CYP2A6 (0.36) MLYCD
SCHEMBL10038695 0.88 CYP2A6 (0.42) MLYCD
SCHEMBL10038683 0.88 PTGDR2 (0.34) MLYCD
SCHEMBL10038687 0.87 KIF11 (0.39) KIF11MLYCDEPHX2
SCHEMBL10038697 0.86
SCHEMBL10038694 0.85 MLYCD (0.31) MLYCD
SCHEMBL10038692 0.85 USP14 (0.31)
SCHEMBL10038702 0.84 KIF11 (0.36) KIF11MLYCD
SCHEMBL10353948 0.83 KIF11 (0.40) KIF11MLYCDEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181527-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-9331285-B2 Aromatic amine derivative and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2016-05-03 US disclosed
US-20120013244-A1 ORGANIC LUMINESCENT MEDIUM IDEMITSU KOSAN CO., LTD. 2012-01-19 US disclosed
US-20110297923-A1 Aromatic amine derivative and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. 2011-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120013244-A1 ORGANIC LUMINESCENT MEDIUM ANXA1, ANXA11, GLB1 KIF11 3738/4885MLYCD 959/4885EPHX2 3257/4885
US-20110297923-A1 Aromatic amine derivative and organic electroluminescent element using same H1-4, H1-2, H1-0 KIF11 2278/4885MLYCD 3140/4885EPHX2 3553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.